Immunotherapy of Prolactinoma with a T Helper 1 Activator Adjuvant and Autoantigens: A Case Report

Publisher： Karger

E-ISSN： 1423-0216|13|4|205-208

ISSN： 1021-7401

Source： Neuroimmunomodulation, Vol.13, Iss.4, 2007-03, pp. : 205-208

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Increased MIB-1/Ki-67 Labeling Index as a Predictor of an Aggressive Course in a Case of Prolactinoma

By  

Hormone Research in Paediatrics, Vol. 61, Iss. 3, 2004-03 ,pp. : 111-116

Karger

Access to resources Recommend Favorite

Effects of the Sympathetic Nervous System on Regulatory T Cell and T Helper 1 Chemokine Expression in Patients with Acute Coronary Syndrome

By  

Neuroimmunomodulation, Vol. 23, Iss. 3, 2016-10 ,pp. : 168-178

Karger

Access to resources Recommend Favorite

Regulation of Differentiation and Function of Helper T Cells by Lymphocyte-Derived Catecholamines via α1- and β2-Adrenoceptors

By  

Neuroimmunomodulation, Vol. 22, Iss. 3, 2014-04 ,pp. : 138-151

Karger

Access to resources Recommend Favorite

Differential Effects of Neuropeptides on Cytokine Production by Mouse Helper T Cell Subsets

By  

Neuroimmunomodulation, Vol. 5, Iss. 1-2, 1998-07 ,pp. : 9-15

Karger

Access to resources Recommend Favorite

Prolactinoma in Children and Adolescents

By  

Hormone Research in Paediatrics, Vol. 72, Iss. 4, 2009-09 ,pp. : 197-205

Karger

Access to resources Recommend Favorite